Healthcare Distribution Alliance
Registered Principal Details
Business Or Interest:
Healthcare
Lobbying Interests:
Issues related to Healthcare and the biennial budget.
CEO Name:
Chip Davis
Healthcare
Lobbying Interests:
Issues related to Healthcare and the biennial budget.
CEO Name:
Chip Davis
Contact
MD
Matthew DiLoreto
901 N. Glebe Rd
Arlington, VA 22203
(703) 684-1110
compliance_WI_HDA@multistate.us
https://www.hda.org/
901 N. Glebe Rd
Arlington, VA 22203
(703) 684-1110
compliance_WI_HDA@multistate.us
https://www.hda.org/
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|
Lobbying Interests
Budget Bill Subjects
Biennial budget bill treatment of matter relating to
Insurance: Departmentwide
Insurance: Departmentwide
Notification Date
2/22/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
2/22/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
Healthcare
Healthcare
Action Intended To Affect
Both Legislative matter and rule
Notification Date
1/13/2023
First Communication Date
1/12/2023
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Both Legislative matter and rule
Notification Date
1/13/2023
First Communication Date
1/12/2023
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Development, drafting or introduction of a proposal relating to
Licensing and regulatory oversight of Pharmacy Services Administrative Organizations
Licensing and regulatory oversight of Pharmacy Services Administrative Organizations
Action Intended To Affect
Both Legislative matter and rule
Notification Date
1/13/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Both Legislative matter and rule
Notification Date
1/13/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Drug pricing
Drug pricing
Action Intended To Affect
Both Legislative matter and rule
Notification Date
1/13/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Both Legislative matter and rule
Notification Date
1/13/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Drug pricing, licensing, and regulatory oversight of Pharmacy Services Administrative Organizations.
Development, drafting or introduction of a proposal relating to
Drug pricing, licensing, and regulatory oversight of Pharmacy Services Administrative Organizations.
Drug pricing, licensing, and regulatory oversight of Pharmacy Services Administrative Organizations.
Action Intended To Affect
Legislative matter
Notification Date
1/4/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Legislative matter
Notification Date
1/4/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Total Lobbying Effort
| 2023 January - June |
2023 July - December |
2024 January - June |
Total | |
|---|---|---|---|---|
| Total Lobbying Expenditures | 2023 January - June $15,000.00 |
2023 July - December $5,000.00 |
2024 January - June $12,000.00 |
Total $32,000.00 |
| Total Hours Communicating | 2023 January - June 5.25 |
2023 July - December 4.00 |
2024 January - June 2.00 |
Total 11.25 |
| Total Hours Other | 2023 January - June 12.75 |
2023 July - December 10.25 |
2024 January - June 9.75 |
Total 32.75 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
No legislative bills/resolutions found.
Budget Bill Subjects
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June 60% |
2023 July - December |
2024 January - June |
2024 July - December |
Total 25% |
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
Drug pricing, licensing, and regulatory oversight of Pharmacy Services Administrative Organizations.
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June |
2023 July - December 80% |
2024 January - June |
2024 July - December |
Total 26% |
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June |
2023 July - December |
2024 January - June 90% |
2024 July - December |
Total 24% |
Minor Efforts
(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)
Other Matters
Includes time spent on:
- Gubernatorial nominations
- Matters on which the organization made no lobbying communication